The Form 4 filing, an SEC report of an insider's stock trades, was filed on Nov. 16, 2026. The reported sales took place four days earlier, on Nov. 12.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-12 |
| Date of Latest Transaction | 2026-11-12 |
| Buy/Sell | sell |
| Transaction Count | 3 |
| Shares Transacted | 13,800 |
| Price | $79.15 |
| Total Transaction Value | $1,092,246.97 |
| Insider | |
| Ticker Symbol | CDNA |
| Company | CareDx, Inc. |
| Insider Name | Goldberg Michael |
| Insider Title | Director |
| Sector - Industry | Healthcare - Diagnostics & Research |
| Holdings | |
| Total Shares Owned After Transaction | 48,526 |
| Position Size Change | 22.14% |
| Filing | |
| Filing Date | 2026-11-16 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
Director Michael Goldberg sold shares of CareDx (CDNA). The transactions use code S, which identifies sales. These are three transactions reported by one insider in a single filing.
What was the average price of the transaction?
The average sale price was $79.15 per share, rounded to the nearest cent. Separate prices for each of the three sales are not available.
How did this transaction affect the insider's holdings?
Michael Goldberg sold 13,800 shares and reported owning 48,526 shares afterward. The shares sold made up 22.14% of his reported shares before the sales.
What's the total transaction value?
The total value of all three sales was $1,092,246.974, which rounds to $1,092,246.97 to the nearest cent.
Are there any special circumstances around this transaction?
The filing information identifies a reference to a Rule 10b5-1 trading plan. These plans set trade instructions in advance. Footnote text and plan terms are not available, so it is unclear which of the three sales the plan covered. The plan's start date and trading schedule are also unknown. The reference alone does not show whether the plan met the rule's legal requirements.
For research purposes only; not investment advice.